|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 38/28 | (2006.01) |
| A61K 38/26 | (2006.01) | ||
| A61P 5/50 | (2006.01) |
| (11) | Number of the document | 2349324 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09783905.4 |
| Date of filing the European patent application | 2009-10-09 | |
| (97) | Date of publication of the European application | 2011-08-03 |
| (45) | Date of publication and mention of the grant of the patent | 2017-09-06 |
| (46) | Date of publication of the claims translation | 2017-12-27 |
| (86) | Number | PCT/EP2009/063195 |
| Date | 2009-10-09 |
| (87) | Number | WO 2010/043566 |
| Date | 2010-04-22 |
| (30) | Number | Date | Country code |
| 102008051834 | 2008-10-17 | DE | |
| 102008053048 | 2008-10-24 | DE | |
| 102009038210 | 2009-08-20 | DE |
| (72) |
WERNER, Ulrich, DE
ROTTHÄUSER, Bärbel, DE
SMITH, Christopher James, GB
|
| (73) |
Sanofi-Aventis Deutschland GmbH,
Brüningstra e 50, 65929 Frankfurt am Main,
DE
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Insulino ir GLP-1 agonisto derinys |
| COMBINATION OF AN INSULIN AND A GLP-1 AGONIST |
| Payment date | Validity (years) | Amount | |
| 2018-09-13 | 10 | 231.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2019-10-09 |